Reporter Oct 8 2021

Rondi Kauffmann, MD, MPH, seated, reviews a patient’s medical history with Vanderbilt University School of Medicine students Natasha Hughes, far left, and Candace Grisham, during a recent surgical clinic.
October 7, 2021

Pandemic spurs expansion of surgical care for underserved

When the COVID-19 pandemic shut down international travel necessary for overseas medical initiatives, Vanderbilt’s Rondi Kauffmann, MD, MPH, began brainstorming ways to extend surgical care to those in need much closer to home.

By Jill Clendening
October 7, 2021

Study seeks to improve kidney transplant outcomes among Black patients

By Bill Snyder
October 7, 2021

Amphibians offer clues to climate change resiliency

By Bill Snyder
ekg results
October 7, 2021

Study finds genetic testing useful for young AFib patients

Vanderbilt research shows that genetic testing in patients with early-onset atrial fibrillation can identify variants associated with more serious cardiomyopathy and arrhythmia syndromes that may otherwise remain undiagnosed.

By Matt Batcheldor
October 7, 2021

Boosta-Palooza

VUMC employees were able to receive a single booster dose of the Pfizer COVID-19 vaccine at this week’s Boosta-Palooza event.

By VUMC News and Communications
October 7, 2021

Nominations sought for VUSM Research Staff Awards

By Bill Snyder
October 7, 2021

Lindenfeld honored by Heart Failure Society of America

Vanderbilt's JoAnn Lindenfeld, MD, has received the Pioneer Award from the Heart Failure Society of America (HFSA) for being an innovator and pioneer in the field of heart failure.
By Matt Batcheldor
October 6, 2021

Lecture details legacies of Levi Watkins, Vivien Thomas

At Tuesday’s Levi Watkins Jr. MD Lecture, George C. Hill, PhD, delivered the keynote address, “Dr. Levi Watkins and Mr. Vivien Thomas: Memories and Lessons Learned from Two Outstanding Lives of Service.”
By Kathy Whitney
October 6, 2021

Pediatricians seeing increase in children with MIS-C after latest COVID surge

By Jessica Pasley
October 5, 2021

AstraZeneca seeks emergency approval for COVID-19 antibodies isolated at VUMC

Biopharmaceutical company AstraZeneca has requested emergency use authorization (EUA) from the U.S. Food and Drug Administration for a long-acting antibody combination originally developed at Vanderbilt University Medical Center to protect against COVID-19.
By Bill Snyder
October 1, 2021

VUMC research contributed to first COVID-19 pill now under review

Vanderbilt research helped allow pharmaceutical giant Merck & Co. to authorization for the first oral antiviral pill to treat COVID-19.
By Bill Snyder
October 1, 2021

VUMC awarded $31.7 million to harmonize Alzheimer’s research data

Vanderbilt University Medical Center has received a $31.7 million federal grant to harmonize research data gathered on human subjects in scores of disparate studies of Alzheimer’s disease and related dementias.
By Paul Govern